HPLC analysis of HI-6 dichloride and dimethanesulfonate - Antidotes against nerve agents and organophosphorus pesticides

Analytical Letters

Volumn 40, Issue 14, 2007, Pages 2783-2787

  Jun, Daniel ^a,b   Kuca, Kamil ^a,b   Stodulka, Petr ^a,c   Koleckar, Vit ^a   Dolezal, Bohuslav ^c   Simon, Peter ^d   Veverka, Miroslav ^e  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c Vakos XT as   (Czech Republic)

^d SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^e Bel/Novamann International Ltd   (Slovakia)

Author keywords

Antidote; Cholinesterase; HI 6; HPLC; Nerve agent; Oxime; Reactivator

Indexed keywords

EID: 35948955541     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710701588531     Document Type: Article

References (15)

1. Bajgar, J., Fusek, J., Kuca, K., Bartosova, L., and Jun, D. 2007. Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. Mini-Rev. Med. Chem., 7: 461-466.
2. Benschop, H.P., Konings, K.A.G., Kossen, S.P., and Ligtenstein, D.A. 1981. Determination of some pyridinium aldoxime compounds by means of ion-pair reversed-phase high-performance liquid chromatography: application in biological material. J. Chromatogr., 225: 107-114.
3. Hagedorn, I. 1973. US Patent, Bis-quaternary pyridinium salts 3: 773, 775.
4. Jun, D., Bajgar, J., and Kuca, K. 2006. In vitro comparison of eight acetylcholinesterase reactivators to reactivate VX inhibited ACHE. Toxicol. Lett., 164: S120-S120.
5. Jun, D., Stodulka, P., Kuca, K., Koleckar, V., Dolezal, B., Simon, P., and Veverka, M. 2007. TLC analysis of intermediates arising during the preparation of oxime HI-6 dimethanesulfonate. J. Chromatogr. Sci., In Press.
6. Krummer, S., Thiermann, H., Worek, F., and Eyer, P. 2002. Equipotent cholinesterase reactivation in vitro by the nerve agent antidotes HI-6 dichloride and HI-6 dimethanesulfonate. Arch. Toxicol., 76: 589-595.
7. Kuca, K., Bartosova, L., Kassa, J., Cabal, J., Bajgar, J., Kunesova, G., and Jun, D. 2005. Comparison of the potency of newly developed and currently available oximes to reactivate nerve agent-inhibited acetylcholinesterase in vitro and in vivo. Chem. Biol. Interact., 157-158: 367-368.
8. Kuca, K., Jun, D., and Musilek, K. 2006. Structural requirements of acetylcholinesterase reactivators. Mini-Rev. Med. Chem., 6: 269-277.
9. Laufer, R., Bathori, M., Csermely, T., Petroianu, G., Kuca, K., Toth, N., and Kalasz, H. 2007. The TLC determination of hydrophilicity parameter of some pyridinium aldoximes. J. Liq. Chromatogr., 30: 2337-2344.
10. Lorke, D.E., Hasan, M.Y., Nurulain, S.M., Sheen, R., Kuca, K., and Petroianu, G.A. 2007. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the brain: comparison with obidoxime. J. Appl. Toxicol., 27: 482-490.
11. Lundy, P.M., Hill, I., Lecavalier, P., Hamilton, M.G., Vair, C., Davidson, C., Weatherby, K.L., and Berger, B.J. 2005. The pharmacokinetics and pharmacodynamics of two HI-6 salts in swine and efficacy in the treatment of GF and soman poisoning. Toxicology, 208: 399-409.
12. Lundy, P.M., Raveh, L., and Amitai, G. 2006. Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol. Rev., 25: 231-243.
13. Sakurada, K., Matsubara, K., Shimizu, K., Shiono, H., Seto, Y., Tsuge, K., Yoshino, M., Sakai, I., Mukoyama, H., and Takatori, T. 2003. Pralidoxime iodide (2-Pam) penetrates across the blood-brain barrier. Neurochem. Res., 28: 1401-1407.
14. Shih, M.L., Smith, J.R., and Salem, G.W. 1990. High-performance liquid chromatographic analysis of imidazolium and pyridinium oximes in plasma and urine. J. Chromatogr., 527: 371-379.
15. Thiermann, H., Seidl, S., and Eyer, P. 1996. HI-6 dimethanesulfonate has better dissolution properties than HI-6 dichloride for application in dry/wet autoinjectors. Int. J. Pharm., 137: 167-176.